{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:52:14Z","timestamp":1790610734260,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Talent Project of Kunming Health Science and Technology","award":["2022-SW [Leading Talents]-001"],"award-info":[{"award-number":["2022-SW [Leading Talents]-001"]}]},{"name":"the Special Project \u201cSpring City Plan\u201d Famous Doctor","award":["C202012016"],"award-info":[{"award-number":["C202012016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11834-1","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:08:48Z","timestamp":1762168128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Repeat testing or additional tuberculin skin tests for management of indeterminate results of interferon-gamma release assays: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Xin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungui","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"5","key":"11834_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1183\/09031936.00120908","volume":"33","author":"U Mack","year":"2009","unstructured":"Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009;33(5):956\u201373.","journal-title":"Eur Respir J."},{"key":"11834_CR2","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","volume":"2","author":"M Pai","year":"2016","unstructured":"Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:16076.","journal-title":"Nat Rev Dis Primers"},{"key":"11834_CR3","volume-title":"Global tuberculosis report 2023","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization; 2023."},{"issue":"4","key":"11834_CR4","doi-asserted-by":"publisher","first-page":"E322","DOI":"10.33321\/cdi.2017.41.43","volume":"41","author":"I Bastian","year":"2017","unstructured":"Bastian I, Coulter C, National Tuberculosis Advisory Committee (NTAC). Position statement on interferon-\u03b3 release assays for the detection of latent tuberculosis infection. Commun Dis Intell Q Rep. 2017;41(4):E322\u201336.","journal-title":"Commun Dis Intell Q Rep."},{"issue":"3","key":"11834_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1086\/338149","volume":"34","author":"E Lee","year":"2002","unstructured":"Lee E, Holzman RS. Evolution and current use of the tuberculin test. Clin Infect Dis. 2002;34(3):365\u201370.","journal-title":"Clin Infect Dis"},{"issue":"9235","key":"11834_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","volume":"356","author":"P Andersen","year":"2000","unstructured":"Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356(9235):1099\u2013104.","journal-title":"Lancet"},{"issue":"5","key":"11834_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","volume":"146","author":"D Menzies","year":"2007","unstructured":"Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146(5):340\u201354.","journal-title":"Ann Intern Med"},{"issue":"12","key":"11834_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"M Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4(12):761\u201376.","journal-title":"Lancet Infect Dis"},{"key":"11834_CR9","doi-asserted-by":"publisher","first-page":"109132","DOI":"10.1016\/j.clim.2022.109132","volume":"245","author":"G Zhou","year":"2022","unstructured":"Zhou G, Luo Q, Luo S, et al. Positive rates of interferon-\u03b3 release assay and tuberculin skin test in detection of latent tuberculosis infection: A systematic review and meta-analysis of 200,000 head-to-head comparative tests. Clin Immunol. 2022;245:109132.","journal-title":"Clin Immunol"},{"issue":"3","key":"11834_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177\u201384.","journal-title":"Ann Intern Med"},{"issue":"4","key":"11834_CR11","doi-asserted-by":"publisher","first-page":"1701267","DOI":"10.1183\/13993003.01267-2017","volume":"50","author":"J Brown","year":"2017","unstructured":"Brown J, Kumar K, Reading J, et al. Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results. Eur Respir J. 2017;50(4):1701267.","journal-title":"Eur Respir J"},{"key":"11834_CR12","first-page":"117057","volume":"14","author":"G Zhou","year":"2023","unstructured":"Zhou G, Luo Q, Luo S, et al. Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis. Front Immunol. 2023;14:117057.","journal-title":"Front Immunol"},{"issue":"11","key":"11834_CR13","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.cmi.2023.07.003","volume":"29","author":"G Zhou","year":"2023","unstructured":"Zhou G, Luo S, He J, et al. Risk of progression to active tuberculosis for indeterminate interferon-gamma release assay in immunocompromised individuals: a systematic review and meta-analysis. Clin Microbiol Infect. 2023;29(11):1375\u201384.","journal-title":"Clin Microbiol Infect"},{"key":"11834_CR14","unstructured":"US Centers for Disease Control and Prevention. Latent tuberculosis infection: a guide for primary health care providers. Available from: www.cdc.gov\/tb\/publications\/ltbi\/default.htm. Accessed 10 Jan 2023."},{"key":"11834_CR15","unstructured":"Infectious Diseases Society of America. Diagnosis of Tuberculosis in Adults and Children: Diagnostic Tests for LTBI. Available from: www.idsociety.org\/practice-guideline\/diagnosis-of-tb-in-adults-and-children\/#DiagnosticTestsforLTBI. Accessed 12 Sept 2024."},{"key":"11834_CR16","unstructured":"Canadian Tuberculosis Committee. Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infectiond 2010 update. 2010. Available from: www.phac-aspc.gc.ca\/publicat\/ccdr-rmtc\/10vol36\/acs-5\/indexeng.php. Accessed 18 Apr 2023."},{"key":"11834_CR17","unstructured":"American Academy of Pediatrics. Tuberculosis Infection in Children and Adolescents. Available from: https:\/\/publications.aap.org\/pediatrics\/article\/148\/6\/e2021054663\/183445\/Tuberculosis-Infection-in-Children-and-Adolescents. Accessed 12 Sept 2024."},{"issue":"1","key":"11834_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"issue":"7414","key":"11834_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"10","key":"11834_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S1473-3099(18)30355-4","volume":"18","author":"I Abubakar","year":"2018","unstructured":"Abubakar I, Drobniewski F, Southern J, et al. Prognostic value of interferon-\u03b3 release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study. Lancet Infect Dis. 2018;18(10):1077\u201387.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"11834_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.5588\/ijtld.13.0813","volume":"18","author":"MC Aichelburg","year":"2014","unstructured":"Aichelburg MC, Mandorfer M, Tittes J, et al. The association of smoking with IGRA and TST results in HIV-1-infected subjects. Int J Tuberc Lung Dis. 2014;18(6):709\u201316.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"11834_CR22","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.5588\/ijtld.11.0017","volume":"15","author":"DB Banach","year":"2011","unstructured":"Banach DB, Harris TG. Indeterminate QuantiFERON\u00ae-TB Gold results in a public health clinic setting. Int J Tuberc Lung Dis. 2011;15(12):1623\u201330.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"11834_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jinf.2012.10.017","volume":"66","author":"F Bartalesi","year":"2013","unstructured":"Bartalesi F, Goletti D, Spinicci M, et al. Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment. J Infect. 2013;66(4):346\u201356.","journal-title":"J Infect"},{"issue":"8","key":"11834_CR24","doi-asserted-by":"publisher","first-page":"e43520","DOI":"10.1371\/journal.pone.0043520","volume":"7","author":"E Bergot","year":"2012","unstructured":"Bergot E, Haustraete E, Malbruny B, Magnier R, Sala\u00fcn MA, Zalcman G. Observational study of QuantiFERON\u00ae-TB gold in-tube assay in tuberculosis contacts in a low incidence area. PLoS ONE. 2012;7(8):e43520.","journal-title":"PLoS ONE"},{"issue":"8","key":"11834_CR25","first-page":"1138","volume":"12","author":"A Bourgarit","year":"2015","unstructured":"Bourgarit A, Baron G, Breton G, et al. Latent tuberculosis infection screening and 2-year outcome in antiretroviral-Naive HIV-infected patients in a low-prevalence country. Ann Am Thorac Soc. 2015;12(8):1138\u201345.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"11834_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00431-022-04640-3","volume":"182","author":"J Calzada-Hern\u00e1ndez","year":"2023","unstructured":"Calzada-Hern\u00e1ndez J, Anton J, Mart\u00edn de Carpi J, et al. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-\u03b1 inhibitor initiation in children in Spain. Eur J Pediatr. 2023;182(1):307\u201317.","journal-title":"Eur J Pediatr."},{"issue":"12","key":"11834_CR27","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s10067-011-1771-9","volume":"30","author":"B Chang","year":"2011","unstructured":"Chang B, Park HY, Jeon K, et al. Interferon-\u03b3 release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Clin Rheumatol. 2011;30(12):1535\u201341.","journal-title":"Clin Rheumatol"},{"key":"11834_CR28","first-page":"217969","volume":"2014","author":"SO Chuke","year":"2014","unstructured":"Chuke SO, Yen NT, Laserson KF, et al. Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa Applicants. Tuberc Res Treat. 2014;2014:217969.","journal-title":"Tuberc Res Treat"},{"issue":"12","key":"11834_CR29","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3899\/jrheum.130303","volume":"40","author":"F Costantino","year":"2013","unstructured":"Costantino F, de Carvalho BM, Rat AC, et al. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-\u03b3 release assay results. J Rheumatol. 2013;40(12):1986\u201393.","journal-title":"J Rheumatol"},{"key":"11834_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/1471-2334-11-319","volume":"11","author":"L Elzi","year":"2011","unstructured":"Elzi L, Steffen I, Furrer H, et al. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB\u2122) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection. BMC Infect Dis. 2011;11:319.","journal-title":"BMC Infect Dis."},{"issue":"9","key":"11834_CR31","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1097\/INF.0000000000000353","volume":"33","author":"S Garazzino","year":"2014","unstructured":"Garazzino S, Galli L, Chiappini E, et al. Performance of interferon-\u03b3 release assay for the diagnosis of active or latent tuberculosis in children in the first 2 years of age: a multicenter study of the Italian Society of Pediatric Infectious Diseases. Pediatr Infect Dis J. 2014;33(9):e226-231.","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"11834_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00296-017-3852-9","volume":"38","author":"J Gonz\u00e1lez-Moreno","year":"2018","unstructured":"Gonz\u00e1lez-Moreno J, Garc\u00eda-Gasalla M, Losada-L\u00f3pez I, et al. IGRA testing in patients with immune-mediated inflammatory diseases: which factors influence the results. Rheumatol Int. 2018;38(2):267\u201373.","journal-title":"Rheumatol Int"},{"issue":"3","key":"11834_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.7205\/MILMED-D-13-00364","volume":"179","author":"DJ Goodwin","year":"2014","unstructured":"Goodwin DJ, Mazurek GH, Campbell BH, et al. Automation of an interferon-\u03b3 release assay and comparison to the tuberculin skin test for screening basic military trainees for Mycobacterium tuberculosis infection. Mil Med. 2014;179(3):333\u201341.","journal-title":"Mil Med"},{"issue":"2","key":"11834_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jpids\/piu119","volume":"5","author":"JA Grinsdale","year":"2016","unstructured":"Grinsdale JA, Islam S, Tran OC, Ho CS, Kawamura LM, Higashi JM. Interferon-gamma release assays and pediatric public health tuberculosis screening: the San Francisco program experience 2005 to 2008. J Pediatric Infect Dis Soc. 2016;5(2):122\u201330.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"11","key":"11834_CR35","first-page":"1190","volume":"11","author":"S Jones","year":"2007","unstructured":"Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, Sacks H. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis. 2007;11(11):1190\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"11834_CR36","doi-asserted-by":"publisher","first-page":"428","DOI":"10.5588\/ijtld.13.0644","volume":"18","author":"YJ Jung","year":"2014","unstructured":"Jung YJ, Lee JY, Jo KW, et al. The \u201ceither test positive\u201d strategy for latent tuberculous infection before anti-tumour necrosis factor treatment. Int J Tuberc Lung Dis. 2014;18(4):428\u201334.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"11834_CR37","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1164\/rccm.201707-1487OC","volume":"197","author":"B Kampmann","year":"2018","unstructured":"Kampmann B, Seddon JA, Paton J, et al. Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study. Am J Respir Crit Care Med. 2018;197(8):1058\u201364.","journal-title":"Am J Respir Crit Care Med."},{"issue":"5","key":"11834_CR38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.5588\/ijtld.10.0555","volume":"15","author":"TS Kasambira","year":"2011","unstructured":"Kasambira TS, Shah M, Adrian PV, et al. QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact. Int J Tuberc Lung Dis. 2011;15(5):628\u201334.","journal-title":"Int J Tuberc Lung Dis"},{"key":"11834_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1471-2334-9-207","volume":"9","author":"EY Kim","year":"2009","unstructured":"Kim EY, Lim JE, Jung JY, et al. Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis. 2009;9:207.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"11834_CR40","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","volume":"11","author":"SH Kim","year":"2011","unstructured":"Kim SH, Lee SO, Park JB, et al. A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant. 2011;11(9):1927\u201335.","journal-title":"Am J Transplant"},{"issue":"2","key":"11834_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1399-3062.2010.00495.x","volume":"12","author":"SH Kim","year":"2010","unstructured":"Kim SH, Lee SO, Park IA, et al. Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation. Transpl Infect Dis. 2010;12(2):113\u20139.","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"11834_CR42","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1183\/09031936.00075008","volume":"33","author":"Y Kobashi","year":"2009","unstructured":"Kobashi Y, Sugiu T, Mouri K, Obase Y, Miyashita N, Oka M. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J. 2009;33(4):812\u20135.","journal-title":"Eur Respir J"},{"issue":"2","key":"11834_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jinf.2014.02.019","volume":"69","author":"YM Lee","year":"2014","unstructured":"Lee YM, Lee SO, Choi SH, et al. A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients. J Infect. 2014;69(2):165\u201373.","journal-title":"J Infect"},{"issue":"1","key":"11834_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3904\/kjim.2014.29.1.76","volume":"29","author":"JH Lee","year":"2014","unstructured":"Lee JH, Sohn HS, Chun JH, et al. Poor agreement between QuantiFERON-TB Gold test and tuberculin skin test results for the diagnosis of latent tuberculosis infection in rheumatoid arthritis patients and healthy controls. Korean J Intern Med. 2014;29(1):76\u201384.","journal-title":"Korean J Intern Med"},{"issue":"7","key":"11834_CR45","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1164\/rccm.200608-1088OC","volume":"175","author":"AF Luetkemeyer","year":"2007","unstructured":"Luetkemeyer AF, Charlebois ED, Flores LL, et al. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med. 2007;175(7):737\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"11834_CR46","first-page":"6682840","volume":"2021","author":"AK Mantri","year":"2021","unstructured":"Mantri AK, Meena P, Puri AS, et al. Comparison of interferon-gamma release assay and tuberculin skin test for the screening of latent tuberculosis in inflammatory bowel disease patients: Indian scenario. Tuberc Res Treat. 2021;2021:6682840.","journal-title":"Tuberc Res Treat"},{"issue":"1","key":"11834_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/1817-1737.58959","volume":"5","author":"M Mardani","year":"2010","unstructured":"Mardani M, Tabarsi P, Mohammadtaheri Z, et al. Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran. Ann Thorac Med. 2010;5(1):43\u20136.","journal-title":"Ann Thorac Med"},{"issue":"SUPPL 9","key":"11834_CR48","first-page":"2140","volume":"73","author":"D Martinez-Lopez","year":"2021","unstructured":"Martinez-Lopez D, Osorio-Ch\u00e1vez J, \u00c1lvarez-Reguera C, Portilla V, Gonzalez-Gay M\u00c1, Blanco R. Epidemiology of latent tuberculosis infection in patients with rheumatic immune-mediated diseases: Single university study of 1117 patients. Arthritis and RheumatologyArthritis Rheum. 2021;73(SUPPL 9):2140.","journal-title":"Arthritis and RheumatologyArthritis Rheum"},{"key":"11834_CR49","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1590\/2175-8239-jbn-2020-0189","volume":"43","author":"G Meinerz","year":"2021","unstructured":"Meinerz G, Silva C, Dorsdt D, et al. Latent tuberculosis screening before kidney transplantation in the South of Brazil. J Bras Nefrol. 2021;43:520\u20139.","journal-title":"J Bras Nefrol"},{"key":"11834_CR50","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/adc.2010.202069","volume":"97","author":"A M\u00e9ndez-Echevarr\u00eda","year":"2012","unstructured":"M\u00e9ndez-Echevarr\u00eda A, Gonz\u00e1lez-Mu\u00f1oz M, Mellado MJ, et al. Interferon-\u03b3 release assay for the diagnosis of tuberculosis in children. Arch Dis Child. 2012;97:514\u20136.","journal-title":"Arch Dis Child"},{"key":"11834_CR51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.12659\/AOT.902989","volume":"22","author":"HH Moon","year":"2017","unstructured":"Moon HH, Park SY, Kim JM, et al. Isoniazid prophylaxis for latent tuberculosis infections in liver transplant recipients in a tuberculosis-endemic area. Ann Transplant. 2017;22:338\u201345.","journal-title":"Ann Transplant"},{"key":"11834_CR52","doi-asserted-by":"publisher","first-page":"e47340","DOI":"10.1371\/journal.pone.0047340","volume":"7","author":"G Nkurunungi","year":"2012","unstructured":"Nkurunungi G, Lutangira JE, Lule SA, et al. Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing. PLoS One. 2012;7:e47340.","journal-title":"PLoS One"},{"key":"11834_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1590\/s1806-37562016000000125","volume":"43","author":"S Oliveira","year":"2017","unstructured":"Oliveira S, Trajman A, Paniago AMM, et al. Frequency of indeterminate results from an interferon-gamma release assay among HIV-infected individuals. J Bras Pneumol. 2017;43:215\u20138.","journal-title":"J Bras Pneumol"},{"issue":"1","key":"11834_CR54","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ibd.21427","volume":"17","author":"P Papay","year":"2011","unstructured":"Papay P, Eser A, Winkler S, et al. Factors impacting the results of interferon-\u03b3 release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17(1):84\u201390.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"11834_CR55","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s10067-012-2049-6","volume":"31","author":"R Scrivo","year":"2012","unstructured":"Scrivo R, Sauzullo I, Mengoni F, et al. Serial interferon-\u03b3 release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents. Clin Rheumatol. 2012;31(11):1567\u201375.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"11834_CR56","doi-asserted-by":"publisher","first-page":"ofaa224","DOI":"10.1093\/ofid\/ofaa224","volume":"7","author":"A Sosa-Moreno","year":"2020","unstructured":"Sosa-Moreno A, Narita M, Spitters C, et al. A targeted screening program for latent tuberculosis infection among hematopoietic cell transplant recipients. Open Forum Infect Dis. 2020;7(7):ofaa224.","journal-title":"Open Forum Infect Dis."},{"issue":"3","key":"11834_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/INF.0000000000003794","volume":"42","author":"ME Tabatneck","year":"2023","unstructured":"Tabatneck ME, He W, Lamb GS, et al. Interferon gamma release assay results and testing trends among patients younger than 2 Years Old at Two US Health Centers. Pediatr Infect Dis J. 2023;42(3):189\u201394.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"11834_CR58","doi-asserted-by":"publisher","first-page":"e13087","DOI":"10.1111\/tid.13087","volume":"21","author":"AJ Wigg","year":"2019","unstructured":"Wigg AJ, Narayana SK, Anwar S, et al. High rates of indeterminate interferon-gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidates. Transpl Infect Dis. 2019;21(3):e13087.","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"11834_CR59","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.arcmed.2011.02.001","volume":"42","author":"R Zrinski Topi\u0107","year":"2011","unstructured":"Zrinski Topi\u0107 R, Zori\u010di\u0107-Letoja I, Pavi\u0107 I, Dodig S. Indeterminate results of QuantiFERON-TB Gold In-Tube assay in nonimmunosuppressed children. Arch Med Res. 2011;42(2):138\u201343.","journal-title":"Arch Med Res"},{"issue":"12","key":"11834_CR60","first-page":"e50581","volume":"15","author":"S Al Nokhatha","year":"2023","unstructured":"Al Nokhatha S, AlKindi F, Alfalasi M, Abdelsalhen M, AlKhyeli F, Alsaber AR. Prevalence of Latent Tuberculosis Infection Among Rheumatology Patients and Management Practices in the United Arab Emirates: A Single-Center Retrospective Cohort Study. Cureus. 2023;15(12):e50581.","journal-title":"Cureus"},{"issue":"3","key":"11834_CR61","first-page":"205521731987546","volume":"5","author":"LE Baldassari","year":"2019","unstructured":"Baldassari LE, Feng J, Macaron G, et al. Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting. Mult Scler J Exp Transl Clin. 2019;5(3):2055217319875467.","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"1","key":"11834_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.7224\/1537-2073.2019-015","volume":"23","author":"AJ Bouley","year":"2021","unstructured":"Bouley AJ, Baber U, Egnor E, Samaan S, Sloane JA. Prevalence of Latent Tuberculosis in the Multiple Sclerosis Clinic and Effect of Multiple Sclerosis Treatment on Tuberculosis Testing. Int J MS Care. 2021;23(1):26\u201330.","journal-title":"Int J MS Care"},{"issue":"4","key":"11834_CR63","doi-asserted-by":"publisher","first-page":"1701267 [pii]","DOI":"10.1183\/13993003.01267-2017","volume":"50","author":"J Brown","year":"2017","unstructured":"Brown J, Kumar K, Reading J, et al. Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results. Eur Respir J. 2017;50(4):1701267 [pii].","journal-title":"Eur Respir J."},{"issue":"17","key":"11834_CR64","doi-asserted-by":"publisher","first-page":"10693","DOI":"10.3390\/ijerph191710693","volume":"19","author":"M Compagno","year":"2022","unstructured":"Compagno M, Navarra A, Campogiani L, et al. Latent tuberculosis infection in haematopoietic stem cell transplant recipients: a retrospective italian cohort study in Tor Vergata University Hospital, Rome. Int J Environ Res Public Health. 2022;19(17):10693.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"11834_CR65","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.arbres.2020.04.011","volume":"58","author":"A Fern\u00e1ndez-Bl\u00e1zquez","year":"2022","unstructured":"Fern\u00e1ndez-Bl\u00e1zquez A, Arg\u00fcelles Men\u00e9ndez P, Sabater-Cabrera C, et al. Diagnosis of Tuberculous Infection in Immunosuppressed Patients and\/or Candidates for Biologics Using a Combination of 2 IGRA Tests: T-SPOT.TB\/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB\/QuantiFERON TB Gold Plus. Arch Bronconeumol. 2022;58(4):305\u201310.","journal-title":"Arch Bronconeumol."},{"key":"11834_CR66","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpeds.2018.04.034","volume":"200","author":"J Gaensbauer","year":"2018","unstructured":"Gaensbauer J, Gonzales B, Belknap R, Wilson ML, O\u2019Connor ME. Interferon-gamma release assay-based screening for pediatric latent tuberculosis infection in an urban primary care network. J Pediatr. 2018;200:202\u20139.","journal-title":"J Pediatr"},{"issue":"9","key":"11834_CR67","doi-asserted-by":"publisher","first-page":"e0184178","DOI":"10.1371\/journal.pone.0184178","volume":"12","author":"CY Hsiao","year":"2017","unstructured":"Hsiao CY, Chiu HY, Wang TS, Tsai TF. Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab. PLoS ONE. 2017;12(9):e0184178.","journal-title":"PLoS ONE"},{"key":"11834_CR68","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1471-2334-12-107","volume":"12","author":"MM Kall","year":"2012","unstructured":"Kall MM, Coyne KM, Garrett NJ, et al. Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study. BMC Infect Dis. 2012;12:107.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"11834_CR69","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/1078345818763868","volume":"24","author":"M Katyal","year":"2018","unstructured":"Katyal M, Leibowitz R, Venters H. IGRA-Based Screening for Latent Tuberculosis Infection in Persons Newly Incarcerated in New York City Jails. J Correct Health Care. 2018;24(2):156\u201370.","journal-title":"J Correct Health Care"},{"issue":"11","key":"11834_CR70","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.5588\/ijtld.15.0370","volume":"19","author":"L Lebina","year":"2015","unstructured":"Lebina L, Abraham PM, Milovanovic M, et al. Latent tuberculous infection in schoolchildren and contact tracing in Matlosana, North West Province, South Africa. Int J Tuberc Lung Dis. 2015;19(11):1290\u20132.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"11834_CR71","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1365-2362.2011.02502.x","volume":"41","author":"P Papay","year":"2011","unstructured":"Papay P, Eser A, Winkler S, et al. Predictors of indeterminate IFN-\u03b3 release assay in screening for latent TB in inflammatory bowel diseases. Eur J Clin Invest. 2011;41(10):1071\u20136.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"11834_CR72","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/tid.12489","volume":"18","author":"PJ Roth","year":"2016","unstructured":"Roth PJ, Grim SA, Gallitano S, Adams W, Clark NM, Layden JE. Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review. Transpl Infect Dis. 2016;18(1):14\u201321.","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"11834_CR73","doi-asserted-by":"publisher","first-page":"ofy184","DOI":"10.1093\/ofid\/ofy184","volume":"5","author":"JC Sharninghausen","year":"2018","unstructured":"Sharninghausen JC, Shapiro AE, Koelle DM, Kim HN. Risk factors for indeterminate outcome on interferon gamma release assay in non-us-born persons screened for latent tuberculosis infection. Open Forum Infect Dis. 2018;5(8):ofy184.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"11834_CR74","doi-asserted-by":"publisher","first-page":"e42592","DOI":"10.1371\/journal.pone.0042592","volume":"7","author":"CC Shu","year":"2012","unstructured":"Shu CC, Wu VC, Yang FJ, et al. Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis. PLoS ONE. 2012;7(8):e42592.","journal-title":"PLoS ONE"},{"issue":"4","key":"11834_CR75","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1097\/MPG.0000000000002428","volume":"69","author":"JP Stevens","year":"2019","unstructured":"Stevens JP, Ballengee CR, Chandradevan R, et al. Performance of interferon-gamma release assays for tuberculosis screening in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2019;69(4):e111\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"11834_CR76","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/flgastro-2017-100951","volume":"9","author":"AA Thi","year":"2018","unstructured":"Thi AA, Abbara A, Bouri S, et al. Challenges in screening for latent tuberculosis in inflammatory bowel disease prior to biologic treatment: a UK cohort study. Frontline Gastroenterol. 2018;9(3):234\u201340.","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"11834_CR77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/ibd\/izx019","volume":"24","author":"RK Vajravelu","year":"2017","unstructured":"Vajravelu RK, Osterman MT, Aberra FN, et al. Indeterminate QuantiFERON-TB Gold increases likelihood of inflammatory bowel disease treatment delay and Hospitalization. Inflamm Bowel Dis. 2017;24(1):217\u201326.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"11834_CR78","doi-asserted-by":"publisher","first-page":"e0187021","DOI":"10.1128\/spectrum.01870-21","volume":"10","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yang Q, Zhou J, et al. Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of Mycobacterium tuberculosis Infections in Immunocompromised Patients: a Real-World Study. Microbiol Spectr. 2022;10(2):e0187021.","journal-title":"Microbiol Spectr"},{"key":"11834_CR79","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3389\/fimmu.2020.02006","volume":"11","author":"C Carranza","year":"2020","unstructured":"Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, Torres M. Diagnosis for latent tuberculosis infection: new alternatives. Front Immunol. 2020;11:2006.","journal-title":"Front Immunol"},{"issue":"2","key":"11834_CR80","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/jpids\/piu024","volume":"4","author":"W Rose","year":"2015","unstructured":"Rose W, Read SE, Bitnun A, et al. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic. J Pediatric Infect Dis Soc. 2015;4(2):96\u2013103.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"11","key":"11834_CR81","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1086\/644754","volume":"30","author":"KJ Cummings","year":"2009","unstructured":"Cummings KJ, Smith TS, Shogren ES, et al. Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting. Infect Control Hosp Epidemiol. 2009;30(11):1123\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"11834_CR82","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1515\/mr-2024-0013","volume":"4","author":"M Guo","year":"2024","unstructured":"Guo M, Shang S, Li M, et al. Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis\/mechanisms of long COVID. Med Rev (2021). 2024;4(5):367\u201383.","journal-title":"Med Rev (2021)"},{"issue":"1","key":"11834_CR83","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1515\/mr-2024-0030","volume":"5","author":"AG Ewing","year":"2024","unstructured":"Ewing AG, Salamon S, Pretorius E, et al. Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology. Med Rev (2021). 2024;5(1):66\u201375.","journal-title":"Med Rev (2021)"},{"issue":"3","key":"11834_CR84","first-page":"299","volume":"12","author":"S Kang","year":"2024","unstructured":"Kang S, Zheng R. Distribution of the causes of fever of unknown origin in China, 2013\u20132022. J Transl Int Med. 2024;12(3):299\u2013307.","journal-title":"J Transl Int Med"},{"issue":"24","key":"11834_CR85","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1039\/D4AN01029A","volume":"149","author":"MRH Chowdhury","year":"2024","unstructured":"Chowdhury MRH, Oladun C, Ariyasingha NM, et al. Rapid lung ventilation MRI using parahydrogen-induced polarization of propane gas. Analyst. 2024;149(24):5832\u201342.","journal-title":"Analyst"},{"issue":"25","key":"11834_CR86","doi-asserted-by":"publisher","first-page":"e202304071","DOI":"10.1002\/chem.202304071","volume":"30","author":"NM Ariyasingha","year":"2024","unstructured":"Ariyasingha NM, Chowdhury MRH, Samoilenko A, et al. Toward lung ventilation imaging using hyperpolarized diethyl ether gas contrast agent. Chemistry. 2024;30(25):e202304071.","journal-title":"Chemistry"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11834-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11834-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11834-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:08:06Z","timestamp":1762171686000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11834-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11834"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11834-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1486"}}